370 related articles for article (PubMed ID: 906404)
101. Immunopathologic changes in patients with cutaneous malignant melanoma following intratumoral inoculation BCG: correlation with cell-mediated immunity.
Lieberman R; Epstein W; Fudenberg HH
Int J Cancer; 1974 Sep; 14(3):401-16. PubMed ID: 4617711
[No Abstract] [Full Text] [Related]
102. A multiphase immunotherapy regimen for human melanoma: clinical and laboratory results.
Levy NL; Seigler HF; Shingleton WW
Cancer; 1974 Oct; 34(4 Suppl):suppl:1548-57. PubMed ID: 4421918
[No Abstract] [Full Text] [Related]
103. Tumor-directed immune reactivity and immunotherapy in malignant melanoma. Current status.
Mavligit G; Gutterman JU; McBride C; Hersh EM
Prog Exp Tumor Res; 1974; 19():222-52. PubMed ID: 4612607
[No Abstract] [Full Text] [Related]
104. A clinical trial of BCG immunotherapy as an adjunct to surgery in the treatment of primary malignant melanoma.
O'Connor TP; Labandter HP; Hiles RW; Bodenham DC
Br J Plast Surg; 1978 Oct; 31(4):317-22. PubMed ID: 361132
[TBL] [Abstract][Full Text] [Related]
105. Intralesional BCG in the treatment of metastatic malignant melanoma.
Mastrangelo MJ; Sulit HL; Prehn LM; Bornstein RS; Yarbro JW; Prehn RT
Cancer; 1976 Feb; 37(2):684-92. PubMed ID: 766947
[TBL] [Abstract][Full Text] [Related]
106. Prolonged BCG treatment of melanoma: does it suppress the immune capacity?
Helander I; Nordman E; Häkkinen IP; Toivanen A
Br J Dermatol; 1979 Oct; 101(4):421-7. PubMed ID: 508607
[TBL] [Abstract][Full Text] [Related]
107. [Immunity reactions and the pharmacotherapy of malignant neoplasms (allergy and cancer)].
Ado VA
Fiziol Zh; 1976; 22(2):265-71. PubMed ID: 791690
[No Abstract] [Full Text] [Related]
108. [Immunological reactivity study of patients with uterine trophoblastic tumors].
Grigorova TM; Stas TA; Kadagidze ZG; Kovaleva VL
Vopr Onkol; 1979; 25(7):86-90. PubMed ID: 225875
[TBL] [Abstract][Full Text] [Related]
109. Immune reactivity in head and neck squamous carcinoma and relevance to the design of immunotherapy trials.
Browder JP; Chretien PB
Semin Oncol; 1977 Dec; 4(4):431-9. PubMed ID: 339354
[No Abstract] [Full Text] [Related]
110. [Immunotherapy with BCG as coadjuvant in the management of malignant melanomas].
Céspedes de Gómez MM; Aguilar Velázquez G; Valles de Cortés Y
Alergia; 1980 Apr; 27(2):69-86. PubMed ID: 7416444
[No Abstract] [Full Text] [Related]
111. [Problems of immunotherapy in malignant melanoblastoma].
Richter J; Duchková H
Rozhl Chir; 1975 Jun; 54(6):411-8. PubMed ID: 1145346
[No Abstract] [Full Text] [Related]
112. Advances in specific immunotherapy of malignant melanoma.
Curiel-Lewandrowski C; Demierre MF
J Am Acad Dermatol; 2000 Aug; 43(2 Pt 1):167-85; quiz 186-8. PubMed ID: 10906637
[TBL] [Abstract][Full Text] [Related]
113. Active immunotherapy with B.C.G. for recurrent malignant melanoma.
Gutterman JU; Mavligit G; McBride C; Frei E; Freireich EJ; Hersh EM
Lancet; 1973 Jun; 1(7814):1208-12. PubMed ID: 4122562
[No Abstract] [Full Text] [Related]
114. [Immunology and melanoma. Theoretical-experimental observations].
Jurado A; Céspedes de Gómez M
Alergia; 1981 Oct; 28(4):145-72. PubMed ID: 7332071
[No Abstract] [Full Text] [Related]
115. Sequential examination of lymphocyte proliferative capacity in patients with malignant melanoma receiving BCG immunotherapy.
Golub SH; Forsythe AB; Morton DL
Int J Cancer; 1977 Jan; 19(1):18-26. PubMed ID: 137880
[TBL] [Abstract][Full Text] [Related]
116. Immunotherapy of malignancies: current status.
Eilber FR; Holmes EC; Morton DL; Ramming KP; Sparks FC
AJR Am J Roentgenol; 1976 May; 126(5):1088-93. PubMed ID: 178234
[TBL] [Abstract][Full Text] [Related]
117. Topical immunotherapy with diphencyprone for in transit and cutaneously metastatic melanoma.
Damian DL; Saw RP; Thompson JF
J Surg Oncol; 2014 Mar; 109(4):308-13. PubMed ID: 24522938
[TBL] [Abstract][Full Text] [Related]
118. [Immunotherapy of melanoma (proceedings)].
Bolund C
Lakartidningen; 1978 Dec; 75(49):4598. PubMed ID: 723350
[No Abstract] [Full Text] [Related]
119. Immunologic studies in lymphoma and leukemia, and exploration of antitumor immunotherapy.
Sokal JE
J Surg Oncol; 1973 Jun; 5(6):557-66. PubMed ID: 4589652
[No Abstract] [Full Text] [Related]
120. [Intranodular treatment with BCG of cutaneous and subcutaneous metastases of malignant melanoma (author's transl)].
Balzarini GP; Cascinelli N; Fontana V; Veronesi U
Tumori; 1974; 60(4):345-52. PubMed ID: 4439501
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]